Kern Chang
Chief Technical Officer Lotte Biologics
Seminars
Monday 3rd November 2025
Accelerating Bioconjugate Development & Manufacturing with LOTTE BIOLOGICS’ ADC Platform
11:00 am
- Exploring a state-of-the-art facility to support ADC development and GMP manufacturing, with completed conjugation process optimization and scale-up studies demonstrating robust performance across distinct conjugation chemistries
- Developing a proprietary hydrophilic linker technology SoluFlex LinkTM designed to enable favorable physicochemical and pharmacological ADC properties
- Establishing a flexible and scalable system to accelerate ADC translation into GMP-compliant materials, supporting rapid clinical progression and ultimately commercial supply
